SARTIANI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 9.794
EU - Europa 6.529
AS - Asia 3.730
SA - Sud America 551
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 145
OC - Oceania 85
Totale 20.985
Nazione #
US - Stati Uniti d'America 9.617
RU - Federazione Russa 1.993
IT - Italia 1.460
PL - Polonia 1.191
SG - Singapore 1.126
CN - Cina 763
HK - Hong Kong 663
IE - Irlanda 499
BR - Brasile 435
SE - Svezia 412
VN - Vietnam 377
KR - Corea 296
DE - Germania 206
FI - Finlandia 196
FR - Francia 177
IN - India 135
GB - Regno Unito 130
UA - Ucraina 103
CA - Canada 101
AU - Australia 83
JP - Giappone 77
JO - Giordania 58
CI - Costa d'Avorio 48
TR - Turchia 45
NG - Nigeria 43
BD - Bangladesh 36
ID - Indonesia 35
MX - Messico 33
AR - Argentina 32
ES - Italia 32
IQ - Iraq 28
EC - Ecuador 27
NL - Olanda 25
CH - Svizzera 24
AT - Austria 19
ZA - Sudafrica 18
LT - Lituania 16
VE - Venezuela 15
BE - Belgio 14
CO - Colombia 13
CL - Cile 10
PH - Filippine 10
PE - Perù 8
PK - Pakistan 8
RO - Romania 8
CR - Costa Rica 7
GR - Grecia 7
HN - Honduras 7
JM - Giamaica 7
KZ - Kazakistan 7
MA - Marocco 7
PY - Paraguay 7
SC - Seychelles 7
TW - Taiwan 7
AZ - Azerbaigian 6
DZ - Algeria 6
OM - Oman 6
TH - Thailandia 6
TN - Tunisia 6
CZ - Repubblica Ceca 5
MY - Malesia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
PR - Porto Rico 4
UZ - Uzbekistan 4
EG - Egitto 3
IL - Israele 3
KE - Kenya 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CG - Congo 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
LY - Libia 2
MQ - Martinica 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
DK - Danimarca 1
HU - Ungheria 1
IS - Islanda 1
KI - Kiribati 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
Totale 20.834
Città #
Santa Clara 1.754
Ashburn 1.229
Warsaw 1.184
Singapore 793
Fairfield 708
Hong Kong 554
Chandler 510
Dublin 495
San Jose 431
Woodbridge 328
Cambridge 315
Seattle 307
Milan 304
Seoul 289
Houston 278
Wilmington 241
Beijing 224
Council Bluffs 178
Altamura 169
Lawrence 168
The Dalles 149
Jacksonville 148
Dallas 145
Princeton 140
Florence 133
Ann Arbor 132
Buffalo 123
Boston 114
Ho Chi Minh City 113
Rome 110
Lauterbourg 104
Boardman 102
Los Angeles 98
Munich 91
Mumbai 82
Melbourne 79
Tokyo 76
Hanoi 70
New York 65
Phoenix 62
Falls Church 58
Hefei 58
Medford 56
Moscow 54
San Diego 52
Abidjan 48
Shanghai 47
Helsinki 45
Abuja 43
São Paulo 42
Paris 34
Turku 33
Redondo Beach 32
Chicago 31
Guangzhou 30
Naples 29
Toronto 27
Columbus 26
Dong Ket 26
Kent 24
Izmir 23
Norwalk 23
Dearborn 22
Frankfurt am Main 22
Tianjin 22
Clifton 20
Jakarta 20
London 20
Montreal 20
Turin 20
Bern 19
Bologna 19
Orem 19
Brasília 18
Andover 17
Figino 17
Chennai 16
Mexico City 16
Palermo 16
Vienna 16
Hillsboro 15
Rio de Janeiro 15
Atlanta 14
Da Nang 14
Siena 14
Manchester 13
Brussels 12
Miano 12
Amman 11
Brooklyn 11
Haiphong 11
Murcia 11
Münster 11
Stockholm 11
Yubileyny 11
Biên Hòa 10
Guayaquil 10
Poggio A Caiano 10
Poplar 10
Baghdad 9
Totale 14.010
Nome #
Role of Nitric Oxide, Nitric Oxide Synthase, Soluble Guanylyl Cyclase, and cGMP-Dependent Protein Kinase I in Mouse Stem Cell Cardiac Development 389
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes 364
Pharmacological perspectives in sarcopenia: A potential role for renin-angiotensin system blockers? 345
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 334
New isoform-selective HCN blockers 328
"β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells, 300
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy 298
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach 295
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 284
Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes. 278
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 277
Angiotensin-II drives human satellite cells toward hypertrophy and myofibroblast trans-differentiation by two independent pathways 267
The funny current in cardiac non-pacemaker cells: functional role and pharmacological modulation 260
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 248
Ranolazine normalizes action potential duration in angiotensin II exposed HL-1 cells: role of late sodium current 243
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 234
Arrhythmia susceptibility in a rat model of acute atrial dilation 232
Prenatal exposure to carbon monoxide delays postnatal cardiac maturation. 222
A molecular basis for HCN channel over-expression. 214
Molecular and functional development of cardiomyocytes differentiated from human embryonic stem cells. 211
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 209
Perturbations of heart development and function in cardiomyocytes from human embryonic stem cells with trisomy 21 208
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 200
SELECTIVITY OF DIFFERENT CALCIUM ANTAGONISTS ON T- AND L-TYPE CALCIUM CURRENTS IN GUINEA-PIG VENTRICULAR MYOCYTES. 199
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 196
Functional expression and subcellular localization of f-channels in native human and HESC-derived cardiomyocytes 194
New phenylalkylamines as isoform selective HCN-Channels blockers 193
Expression of the hyperpolarization-activated current, I(f), in cultured adult rat ventricular cardiomyocytes and its modulation by hypertrophic factors 193
Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiological maturation of the rat heart: a potential substrate for arrhythmogenesis in infancy 193
5-HT2 receptors enable cardiac differentiation of mouse embryonic stem cells 188
Endothelin-1 promotes cellular electrophysiological remodeling by affecting IKr expression in cardiac HL-1 cells. 184
Modulation of Redox Signaling in Chronic Diseases and Regenerative Medicine 184
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 182
Functional remodeling in post-myocardial infarcted rats: focus on beta-adrenoceptor subtypes. 178
Action potential modelling predicts electrophysiological and pharmacological features of human embryonic stem cell-derived cardiomyocytes. 175
n-3 polyunsaturated fatty acid supplementation reduces asymmetric dimethylarginine and arachidonate accumulation in spontaneously hypertensive rats 173
Design, synthesis and electrophysiological studies of new blockers of HCN channels 173
Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue. 173
Beta1 and Beta2 adrenoceptors in human ventricular myocytes: a study of their proportion and signaling pathways. 172
Cardiac myocytes functional markers in embryonic stem cell-derived myocytes 170
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels 170
The HCN channel as a pharmacological target: Why, where, and how to block it 168
Electrophysiological evaluation of novel blockers of If current. 166
Chronic exposure to endothelin-1 prolongs repolarization and hampers rapid delayed rectifier current of cardiac HL-1 cells. 166
Voltage-dependent inward ion channel currents in immortalized HL-1 cells 166
Chronic treatment with omega3-PUFA decreases plasma concentration of asymmetric dimethyl arginine (ADMA) in aged spontaneously hypertensive rat (SHR). 165
Cardiac and Electrophysiological Effects of Primary and Refined Extracts from Leonurus cardiacaL. (Ph.Eur.) 164
Updates on HCN channels in the heart: Function, Dysfunction and pharmacology 164
alpha- and beta-Adrenoceptor modulation of the electrophysiological properties of ventricular myocytes from human failing hearts. 162
Fast Optical Investigation of Cardiac Electrophysiology by Parallel Detection in Multiwell Plates 161
Human amniotic fluid stem cell differentiation along smooth muscle lineage. 158
HCN Channels Modulators: The Need for Selectivity 158
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 158
First Evidence of Cardiac Stem Cells from the Left Ventricular Apical Tip in Patients with Left Ventricular Assist Device Implantation 158
Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive rats. 157
Interleukin-6 Modulates the Expression and Function of HCN Channels: A Link Between Inflammation and Atrial Electrogenesis 156
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 156
Electrophysiological and molecular remodeling in septal myocytes from fHCM patients 155
Does recombinant human interleukin 11 exert direct electrophysiologic effects on single human atrial myocytes? 154
Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes. 154
Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells. 153
Electrophysiologic effects of lercanidipine on repolarizing potassium currents. 152
Dopamine agonists and valvular heart disease. 148
Electrophysiological changes in heart failure: focus on pacemaker channels 147
Neural Effects on Cardiac Electrophysiology 146
ISOLATED CARDIAC CELLS FOR ELECTROPHARMACOLOGICAL STUDIES. 146
Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells). 145
Restoration of Cardiomyocyte Functional Properties byAngiotensin II Receptor Blockade in Diabetic Rats 143
Semicarbazide-sensitive amine oxidases in heart and bovine serum. 143
Characterization of pacemaker current If in immortalized HL-1 cardiomyocytes. 141
Electrophysiological remodeling in post-myocardial infarcted rats: focus on f-current and heart rate. 139
Influence of postnatal-development on If occurrence and properties in neonatal rat ventricular myocytes. 138
Arrhythmogenic alterations in failing human ventricular myocytes. 137
Functional expression of the hyperpolarization-activated, non-selective cation current I(f) in immortalized HL-1 cardiomyocytes 136
Holt-oram syndrome and atrial fibrillation: opening the (T)-box 135
Serotonin 5-HT2 receptors are essential for in-vitro cardiac differentiation of mouse embryonic stem cells. 135
Fetal bovine serum enables cardiac differentiation of human embryonic stem cells. 134
The pacemaker channel and its modulation by ageing, development, and disease: physiopathological and pharmacological implications. 134
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 134
The effect of antineoplastic drugs on commitment, differentiation and maturation of embryonic stem cells toward cardiomyocytes 134
Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation. 134
Transthyretin aggregates affect viability and electrical properties of cardiomyocytes 134
Embryonic stem cells as a model to study the effect of antineoplastic drugs. 134
Chronic treatment of old hypertensive rats with irbesartan restores the electrophysiological and contractile properties of ventricular myocytes. 132
Farmaci per il trattamento delle aritmie cardiache 131
Effect of 8-week treatment with irbesartan of spontaneously hypertensive rats on the electrophysiologic alterations associated with the development of myocardial hypertrophy. 131
Nuovi bloccanti isoforma-selettivi dei canali HCN. 128
Electropysiologic effects of lercanidipine on repolarizing potassium currents 127
Nitroso-Redox Balance in the Regulation of Myocardial Function: a Position Paper from the Italian Society of Cardiovascular Research (SIRC). 127
n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats. 126
MECCANISMI FISIOPATOLOGICI DELLA FIBRILLAZIONE ATRIALE (O DELLE FIBRILLAZIONI ATRIALI) 124
Prenatal exposure to carbon monoxide delays post-natal electrophysiologic maturation of rat ventricular myocytes 124
Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitability 124
Electrophysiologic effects of rhIL-11 on single human atrial myocytes. 121
Smoking and sudden infant death syndrome: electrophysiological insights from an experimental model. 120
FARMACI ANTIARITMICI 119
Prenatal exposure to carbon monoxide temporarily impairs maturation of rat cardiomyocytes: Electrophysiological evidence. 117
Mathematical modelling of electrotonic interaction between stem cell-derived cardiomyocytes and fibroblasts. 112
Developmental changes of cardiomyocytes differentiated from human embryonic stem cells: combined molecular and functional approaches 112
Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiologic remodeling of the rat heart. 112
Totale 17.885
Categoria #
all - tutte 60.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022787 0 0 64 56 49 37 25 72 44 33 126 281
2022/20232.220 227 446 73 150 183 419 269 119 212 26 49 47
2023/2024699 35 101 138 37 36 90 38 113 8 19 40 44
2024/20255.526 194 611 422 794 1.534 707 91 427 261 127 203 155
2025/20266.078 583 755 388 374 598 348 771 343 497 379 169 873
2026/2027875 139 228 508 0 0 0 0 0 0 0 0 0
Totale 20.985